Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Population Health | 3 | 2024 | 54 | 1.810 |
Why?
|
| Pharmacogenetics | 5 | 2024 | 263 | 1.320 |
Why?
|
| Genomics | 15 | 2024 | 2819 | 1.100 |
Why?
|
| Laboratories | 3 | 2024 | 141 | 0.860 |
Why?
|
| Computer Security | 1 | 2019 | 41 | 0.670 |
Why?
|
| Genetic Testing | 6 | 2021 | 1675 | 0.630 |
Why?
|
| Medical Records | 1 | 2019 | 425 | 0.620 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2024 | 5716 | 0.510 |
Why?
|
| Proteins | 7 | 2013 | 1989 | 0.490 |
Why?
|
| Genome, Human | 6 | 2021 | 1897 | 0.450 |
Why?
|
| Neptune | 1 | 2021 | 6 | 0.400 |
Why?
|
| Databases, Protein | 6 | 2015 | 102 | 0.320 |
Why?
|
| Protein Conformation | 5 | 2015 | 1271 | 0.310 |
Why?
|
| Cardiovascular Diseases | 4 | 2023 | 2352 | 0.290 |
Why?
|
| Evolution, Molecular | 6 | 2015 | 856 | 0.280 |
Why?
|
| Electronic Health Records | 4 | 2023 | 972 | 0.280 |
Why?
|
| Staphylococcus aureus | 1 | 2010 | 559 | 0.280 |
Why?
|
| Sequence Analysis, Protein | 3 | 2015 | 82 | 0.260 |
Why?
|
| Software | 5 | 2021 | 1355 | 0.260 |
Why?
|
| Computational Biology | 5 | 2020 | 1299 | 0.230 |
Why?
|
| Clinical Laboratory Services | 1 | 2024 | 42 | 0.230 |
Why?
|
| Genetics, Medical | 2 | 2021 | 143 | 0.220 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2024 | 2341 | 0.220 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2023 | 83 | 0.200 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2022 | 42 | 0.200 |
Why?
|
| Precision Medicine | 3 | 2024 | 1201 | 0.190 |
Why?
|
| Neoplasms, Adipose Tissue | 1 | 2020 | 9 | 0.180 |
Why?
|
| Multifactorial Inheritance | 1 | 2021 | 161 | 0.180 |
Why?
|
| Organizational Case Studies | 1 | 2019 | 44 | 0.180 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2022 | 230 | 0.180 |
Why?
|
| Whole Genome Sequencing | 1 | 2022 | 355 | 0.180 |
Why?
|
| Pancreatitis | 1 | 2022 | 279 | 0.170 |
Why?
|
| United States | 5 | 2024 | 16339 | 0.170 |
Why?
|
| Gastritis | 1 | 2022 | 379 | 0.160 |
Why?
|
| Medical Informatics | 1 | 2021 | 199 | 0.160 |
Why?
|
| Enzymes | 4 | 2013 | 65 | 0.160 |
Why?
|
| Hypoglycemia | 1 | 2020 | 215 | 0.160 |
Why?
|
| Molecular Sequence Annotation | 3 | 2013 | 200 | 0.150 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2019 | 203 | 0.150 |
Why?
|
| Abdominal Neoplasms | 1 | 2020 | 235 | 0.150 |
Why?
|
| Genetic Variation | 3 | 2021 | 2112 | 0.150 |
Why?
|
| Clinical Protocols | 1 | 2020 | 471 | 0.150 |
Why?
|
| Information Dissemination | 1 | 2018 | 274 | 0.130 |
Why?
|
| Exome | 1 | 2021 | 1272 | 0.130 |
Why?
|
| Exons | 1 | 2019 | 1357 | 0.130 |
Why?
|
| Cardiology | 1 | 2021 | 585 | 0.130 |
Why?
|
| Humans | 23 | 2024 | 270843 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2020 | 1000 | 0.120 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 1094 | 0.120 |
Why?
|
| Seizures | 1 | 2020 | 999 | 0.110 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 446 | 0.110 |
Why?
|
| Pharmacogenomic Testing | 2 | 2024 | 47 | 0.110 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 1091 | 0.110 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 1538 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 4646 | 0.100 |
Why?
|
| Molecular Biology | 1 | 2013 | 182 | 0.100 |
Why?
|
| Phenotype | 2 | 2020 | 6404 | 0.100 |
Why?
|
| Biochemistry | 1 | 2010 | 23 | 0.090 |
Why?
|
| Cohort Studies | 4 | 2021 | 9487 | 0.090 |
Why?
|
| Likelihood Functions | 1 | 2010 | 238 | 0.090 |
Why?
|
| Algorithms | 5 | 2013 | 3988 | 0.090 |
Why?
|
| Proteome | 2 | 2013 | 577 | 0.090 |
Why?
|
| Cloning, Molecular | 1 | 2010 | 1226 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2010 | 1083 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 3 | 2020 | 2506 | 0.070 |
Why?
|
| Models, Genetic | 1 | 2010 | 1132 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 6196 | 0.070 |
Why?
|
| Genotype | 2 | 2024 | 4168 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2010 | 1205 | 0.060 |
Why?
|
| Knowledge Bases | 1 | 2024 | 48 | 0.060 |
Why?
|
| Information Storage and Retrieval | 1 | 2024 | 143 | 0.060 |
Why?
|
| Proteomics | 1 | 2010 | 1423 | 0.050 |
Why?
|
| Penetrance | 1 | 2023 | 134 | 0.050 |
Why?
|
| Proprotein Convertase 9 | 1 | 2023 | 70 | 0.050 |
Why?
|
| Health Level Seven | 1 | 2021 | 3 | 0.050 |
Why?
|
| Laboratory Proficiency Testing | 1 | 2020 | 21 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 430 | 0.040 |
Why?
|
| Reference Values | 1 | 2021 | 1129 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2020 | 158 | 0.040 |
Why?
|
| Computer Communication Networks | 1 | 2018 | 44 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 691 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2024 | 1615 | 0.040 |
Why?
|
| Polyps | 1 | 2018 | 78 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2020 | 427 | 0.040 |
Why?
|
| Cardiac Myosins | 1 | 2017 | 18 | 0.040 |
Why?
|
| Tropomyosin | 1 | 2017 | 39 | 0.040 |
Why?
|
| Connectin | 1 | 2017 | 32 | 0.040 |
Why?
|
| LIM Domain Proteins | 1 | 2017 | 108 | 0.040 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 458 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2017 | 130 | 0.040 |
Why?
|
| Acute Disease | 1 | 2022 | 2471 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2022 | 1084 | 0.040 |
Why?
|
| Hyperlipidemias | 1 | 2018 | 247 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 160 | 0.030 |
Why?
|
| Syndrome | 1 | 2020 | 1382 | 0.030 |
Why?
|
| Pedigree | 1 | 2020 | 1937 | 0.030 |
Why?
|
| Base Sequence | 1 | 2022 | 4932 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2023 | 13310 | 0.030 |
Why?
|
| Prevalence | 1 | 2023 | 3399 | 0.030 |
Why?
|
| Colon | 1 | 2018 | 677 | 0.030 |
Why?
|
| Neoplasms | 1 | 2020 | 15710 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2017 | 567 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2013 | 117 | 0.030 |
Why?
|
| Exoribonucleases | 1 | 2013 | 42 | 0.030 |
Why?
|
| Male | 5 | 2022 | 127630 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2013 | 281 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2017 | 896 | 0.030 |
Why?
|
| Species Specificity | 1 | 2013 | 778 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2012 | 559 | 0.020 |
Why?
|
| Myocardium | 1 | 2017 | 1335 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 1462 | 0.020 |
Why?
|
| Structural Homology, Protein | 1 | 2009 | 42 | 0.020 |
Why?
|
| Adult | 3 | 2023 | 80709 | 0.020 |
Why?
|
| Forecasting | 1 | 2013 | 707 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2017 | 2055 | 0.020 |
Why?
|
| Female | 4 | 2022 | 147292 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2009 | 1006 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2021 | 7170 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2009 | 847 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 1049 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 4462 | 0.020 |
Why?
|
| Phylogeny | 1 | 2009 | 847 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 5930 | 0.020 |
Why?
|
| Risk Factors | 1 | 2023 | 18267 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2009 | 1769 | 0.020 |
Why?
|
| Internet | 1 | 2009 | 730 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2020 | 16792 | 0.010 |
Why?
|
| Middle Aged | 2 | 2018 | 89535 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 22140 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 32336 | 0.010 |
Why?
|
| Animals | 2 | 2013 | 61014 | 0.010 |
Why?
|
| Child | 1 | 2017 | 30200 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 15642 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 72902 | 0.010 |
Why?
|